ASND vs. TGTX
ASND (Ascendis Pharma A/S) and TGTX (TG Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, ASND returned 32.30%/yr vs 24.56%/yr for TGTX. At a 0.28 correlation, their price movements are largely independent.
Performance
ASND vs. TGTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ASND achieves a 6.92% return, which is significantly lower than TGTX's 82.49% return. Over the past 10 years, ASND has outperformed TGTX with an annualized return of 32.30%, while TGTX has yielded a comparatively lower 24.56% annualized return.
ASND
- 1D
- -1.23%
- 1M
- -7.71%
- YTD
- 6.92%
- 6M
- 8.87%
- 1Y
- 28.89%
- 3Y*
- 37.25%
- 5Y*
- 10.44%
- 10Y*
- 32.30%
TGTX
- 1D
- 2.22%
- 1M
- 39.95%
- YTD
- 82.49%
- 6M
- 74.81%
- 1Y
- 51.03%
- 3Y*
- 32.10%
- 5Y*
- 7.49%
- 10Y*
- 24.56%
ASND vs. TGTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ASND Ascendis Pharma A/S | 6.92% | 54.89% | 9.31% | 3.13% | -9.22% | -19.34% | 19.88% | 122.06% | 56.39% | 97.92% |
TGTX TG Therapeutics, Inc. | 82.49% | -0.96% | 76.23% | 44.38% | -37.74% | -63.48% | 368.65% | 170.73% | -50.00% | 76.34% |
Correlation
The correlation between ASND and TGTX is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.28 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.33 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.29 |
Correlation (All Time) Calculated using the full available price history since Jan 28, 2015 | 0.29 |
Fundamentals
ASND:
$14.71B
TGTX:
$8.71B
ASND:
€8.08
TGTX:
$2.87
ASND:
24.69
TGTX:
18.93
ASND:
0.11
TGTX:
0.03
ASND:
14.42
TGTX:
12.49
ASND:
26.35
TGTX:
14.93
ASND:
€867.51M
TGTX:
$700.35M
ASND:
€764.89M
TGTX:
$581.54M
ASND:
-€6.94M
TGTX:
$156.88M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ASND vs. TGTX — Risk / Return Rank
ASND
TGTX
ASND vs. TGTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ascendis Pharma A/S (ASND) and TG Therapeutics, Inc. (TGTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ASND | TGTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.29 | ||
| Sortino ratioReturn per unit of downside risk | -0.41 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 1.22 | -0.07 |
| Calmar ratioReturn relative to maximum drawdown | 1.67 | 1.57 | +0.10 |
| Martin ratioReturn relative to average drawdown | 5.00 | 2.84 | +2.16 |
Loading charts...
Drawdowns
ASND vs. TGTX - Drawdown Comparison
The maximum ASND drawdown since its inception was -61.72%, smaller than the maximum TGTX drawdown of -99.52%. Use the drawdown chart below to compare losses from any high point for ASND and TGTX.
Loading charts...
Drawdown Indicators
| ASND | TGTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -61.72% | -99.52% | +37.80% |
Max Drawdown (1Y)Largest decline over 1 year | -17.62% | -32.66% | +15.04% |
Max Drawdown (3Y)Largest decline over 3 years | -29.15% | -74.79% | +45.64% |
Max Drawdown (5Y)Largest decline over 5 years | -60.46% | -90.75% | +30.29% |
Max Drawdown (10Y)Largest decline over 10 years | -61.72% | -93.19% | +31.47% |
Current DrawdownCurrent decline from peak | -8.74% | -76.70% | +67.96% |
Average DrawdownAverage peak-to-trough decline | -18.88% | -91.41% | +72.53% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.84% | 18.03% | -12.19% |
Volatility
ASND vs. TGTX - Volatility Comparison
Ascendis Pharma A/S (ASND) and TG Therapeutics, Inc. (TGTX) have volatilities of 13.54% and 14.05%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ASND | TGTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.54% | 14.05% | -0.51% |
Volatility (6M)Calculated over the trailing 6-month period | 28.50% | 34.07% | -5.57% |
Volatility (1Y)Calculated over the trailing 1-year period | 37.07% | 47.18% | -10.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 48.68% | 87.84% | -39.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 51.06% | 86.87% | -35.81% |
Dividends
ASND vs. TGTX - Dividend Comparison
Neither ASND nor TGTX has paid dividends to shareholders.
Financials
ASND vs. TGTX - Financials Comparison
This section allows you to compare key financial metrics between Ascendis Pharma A/S and TG Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ASND and TGTX have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TGTX has higher volatility (14.05%) compared to ASND (13.54%). In terms of maximum drawdown, ASND dropped -61.72% vs TGTX's -99.52%.
TGTX currently has the higher Sharpe Ratio (1.09 vs 0.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ASND and TGTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer